Bain Capital Specialty Finance (NYSE:BCSF – Get Free Report) had its target price raised by research analysts at Wells Fargo & Company from $15.00 to $16.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price objective would suggest a potential downside of 3.21% from the stock’s previous close.
Bain Capital Specialty Finance Trading Down 0.1 %
Shares of NYSE:BCSF traded down $0.02 during midday trading on Wednesday, reaching $16.53. 139,563 shares of the company’s stock traded hands, compared to its average volume of 274,854. Bain Capital Specialty Finance has a one year low of $11.31 and a one year high of $16.94. The stock has a 50 day moving average of $15.91 and a 200 day moving average of $15.48. The company has a current ratio of 2.18, a quick ratio of 2.18 and a debt-to-equity ratio of 1.11.
Bain Capital Specialty Finance (NYSE:BCSF – Get Free Report) last posted its earnings results on Tuesday, February 27th. The company reported $0.54 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.54. Bain Capital Specialty Finance had a net margin of 41.43% and a return on equity of 12.54%. The business had revenue of $74.95 million for the quarter. On average, research analysts forecast that Bain Capital Specialty Finance will post 2.07 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Bain Capital Specialty Finance
Bain Capital Specialty Finance Company Profile
Bain Capital Specialty Finance, Inc is business development company specializing in direct loans to middle-market companies. The fund seeks to invest in senior investments with a first or second lien on collateral, senior first lien, stretch senior, senior second lien, unitranche, mezzanine debt, junior securities, other junior investments, and secondary purchases of assets or portfolios that primarily consist of middle-market corporate debt.
Featured Stories
- Five stocks we like better than Bain Capital Specialty Finance
- How to Invest in Biotech Stocks
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- What is the S&P/TSX Index?
- Generac Powers Ahead on the Electrification Mega-Trend
- Profitably Trade Stocks at 52-Week Highs
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Bain Capital Specialty Finance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bain Capital Specialty Finance and related companies with MarketBeat.com's FREE daily email newsletter.